Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Go back to Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives| Asianada, Inc. (NASDAQ: ASND) | Delayed: 228.00 -2.83 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.83 | 52 Week High | $21.79 | |||
| Open | $233.00 | 52 Week Low | $11.92 | |||
| Day High | $236.90 | P/E | N/A | |||
| Day Low | $227.13 | EPS | $-0.07 | |||
| Volume | 560,738 | |||||
| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 1.83 -0.18 (8.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $3.64 | |||
| Open | $2.03 | 52 Week Low | $0.14 | |||
| Day High | $2.03 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $0.00 | |||
| Volume | 469,277 | |||||
